Certificate under Reg 74(5) of the SEBI (Depositories and Participants) regulations, 2018 for quarter ended March 31, 2025.
Awaiting price reaction for this filing.
Sanofi Consumer Healthcare India Limited has submitted to BSE and NSE a certificate from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2025. The certificate confirms that securities received from depository participants for dematerialisation during the quarter were properly confirmed to the depositories and listed on the stock exchanges. It also confirms that physical share certificates received for dematerialisation were mutilated and cancelled after verification, with the depositories' names recorded as the registered owners in the company's register of members within the prescribed timelines.
This is a routine quarterly compliance filing and has no material impact on the company's financials or share price. It is a standard regulatory disclosure confirming proper handling of share dematerialisation activity during the quarter.